HomeAI · summaries
Storia in 3 fonti
FDA approves Afrezza for children and adolescents with diabetes
The FDA has approved technosphere insulin, an inhaled form of human insulin, for children and adolescents aged 6 years and older with type 1 and type 2 diabetes, according to an industry press release. Technosphere insulin (Afrezza, MannKind) is a form of insulin delivered through an inhaler that allows for ultra-rapid absorption in the lungs. According to the press release, the insulin’s rapid
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves Afrezza for children and adolescents with diabetes
The FDA has approved technosphere insulin, an inhaled form of human insulin, for children and adolescents aged 6 years and older with type 1 and type 2 diabetes, according to an…
- ·
fiercepharma.com
MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
With a pediatric approval in hand for Afrezza, MannKind believes that it finally has the boost it needs to make an impact in the market after struggling for more than a decade…
- ·
abcnews.com
Inhaled insulin now FDA-approved for kids 6 and over with diabetes
Afrezza is the first needle-free form of insulin FDA-approved for pediatric patients.